Metrics as of 10/14/2026, 09:24 AM (Berlin time), refresh in progress.
Avacta Group Stock
Avacta Group Plc
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United Kingdom
- CEO
- Christina Marie Coughlin
- Employees
- 81
- Market cap
- £301 M
- IPO
- 08/09/2003
Avacta Group Plc operates as a clinical-stage biopharmaceutical company, specializing in the development of cancer therapies and diagnostic solutions. These advancements are driven by its proprietary Affimer and pre|CISION technology platforms, with the company's activities spanning the United Kingdom, North America,…
Avacta Group stock: price history
1D
+1.1%
1W
+1.1%
1M
-15.0%
6M
-13.2%
YTD
+10.7%
1Y
-8.3%
2Y
+1.1%
5Y
-48.1%
10Y
-27.8%
Next earnings date
Next earnings date
22/04/2027 (in 187 days)
Volatility around earnings
~30% stronger price swings than usual
Ask the agents about Avacta Group
Avacta Group stock metrics
P/E
-7.04
P/B
76.56
EV/EBITDA
-9.8
RETURN ON EQUITY
-504.7%
NET MARGIN
-33,969.6%
DEBT/EQUITY
5.27
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
91.2%
FLOAT SHARES
427,167,960
AVG. DAILY VOLUME (30D)
1,778,472
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Avacta Group stock
What does Avacta Group do?
Avacta Group Plc is a company in the Healthcare sector, Biotechnology industry, headquartered in United Kingdom.
The CEO is Christina Marie Coughlin, the company employs around 81 people.
The IPO was on 08/09/2003; the stock trades on LSE under the ticker AVCT.L.
When does Avacta Group report next?
The next earnings date is 22/04/2027.
Around past earnings, price swings were roughly 30% stronger than usual.
Does Avacta Group pay a dividend?
No, Avacta Group currently does not pay a dividend.
Which stocks are comparable to Avacta Group?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines, Incyte and Genmab A/S.
How can I get Avacta Group stock analyzed?
Clicking "Analyze stock" lets five strategies assess Avacta Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.